Evommune, Inc.
Clinical trials sponsored by Evommune, Inc., explained in plain language.
-
New treatment trial offers hope for eczema sufferers
Disease control Recruiting nowThis study is testing whether an investigational medication called EVO756 can help adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare different doses of EVO756 against a placebo in 120 participants to see how well it reduces skin inflammation and …
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Apr 02, 2026 06:57 UTC
-
New hope for people with uncontrollable hives
Disease control Recruiting nowThis study is testing a new drug called EVO756 to see if it can reduce the severity of chronic hives in adults. It will compare several doses of the drug against a placebo in 160 people whose hives are not well-controlled by standard allergy pills. The main goal is to see how muc…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC